Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-09-20
2000-10-10
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 514318, 514211, 514321, 514326, 514367, 514278, 514290, 514319, 514320, 514322, 514323, 514324, 544364, 544366, 544368, 544370, 546194, 546198, 546209, 546 17, 546101, 546110, 546202, 548159, 548160, 548165, 540551, A61K 31495, C07D41712, C07D41714, C07D40312
Patent
active
061302171
ABSTRACT:
This invention relates to certain heterocyclic compounds and their pharmaceutically acceptable salts, which are useful for sensitizing multidrug-resistant tumor cells to anticancer agents and multidrug resistant forms of malaria, tuberculosis, leishmania and amoebic dysentery to chemotherapeutants. The compounds and their pharmaceutically acceptable salts are also inhibitors of the active drug transport capability of P-glycoprotein which is encoded by the human MDR1 gene, as well as of certain other related ATP-binding-cassette transporters from eukaryotic and prokaryotic organisms (e.g., pfmdr from Plasmodium falciprum, and murine mdr1 and mdr3 gene products).
REFERENCES:
patent: 4996321 (1991-02-01), Baldwin et al.
patent: 5364843 (1994-11-01), King
patent: 5622953 (1997-04-01), Janssen et al.
Bellamy et al, Cancer Investigation 8(5), p547-562, (1990).
Fukazawa et al. Chemical Abstracts, vol. 113, No. 152477 (Abstract for JP 02121966, May 9, 1990).
Derwent 92-204506/25 Mitsui Toatsu Chem, Inc., Abstract for JP 4-134070 (May 7, 1992).
W. Sato et al., Cancer Research 51, 2420-2424, May 1, 1991.
V. Brizzi et al., II Farmaco, 47 (6), 953-966; 1992.
J. B. Press et al., J. Med. Chem., 35 (24), Nov., 1992, 4509-4515.
Sircar et al., J. Med. Chem., 1992, 35, 4442-4449.
Fukazawa et al Chemical Abstracts, vol. 117, No. 23, Abs. No. 233859m. (1992).
Fukazawa et al Chemical Abstracts, vol. 113, No. 13, Abs. No. 109311e. (1990).
Arnold Lee Daniel
Coe Jotham Wadsworth
Kaneko Takushi
Moyer Mikel Paul
Bernhardt Emily
Dryer Mark
Ginsburg Paul H.
Pfizer Inc
Richardson Peter C.
LandOfFree
Compounds enhancing antitumor activity of other cytotoxic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds enhancing antitumor activity of other cytotoxic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds enhancing antitumor activity of other cytotoxic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2257131